Diabetes mellitus hospitalization and mortality rate according to a national database in Brazil: a longitudinal study

Florêncio, Rêncio Bento; Fonseca, Luiza Gabriela de Araújo; Silva, Vivian Fernanda Dantas da; Lima, Íllia Nadinne Dantas Florentino; Gualdi, Lucien Peroni

doi:10.1186/s12889-021-10438-z

Cited by 8 publications

(5 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In 2016, a study analyzed the sex differences in DM-related mortality in Brazil from 1980 to 2012 and they also observed an upward mortality trend for both males and females, with an initial female predominance and a reversal in predominance from 2011 onwards [14]. In 2021, Florencio and colleagues compared the hospitalization rate and mortality rate related to DM between 2008 and 2019 in Brazil, and similar to our findings, they reported an increase, which was higher for men than women [15]. This increased mortality rate amongst men could be explained by the fact that men are more likely to have diabetes than women as proposed by an analysis in India and in Spain [16,17], and thus more likely to die from its complications.…”

Section: Type 1 Diabetes Based On Sexsupporting

confidence: 76%

Diabetes Mellitus Mortality Trends in Brazil From 2000 to 2021: An In-Depth Joinpoint Analysis

McBenedict,

Hauwanga,

Lizarazo

et al. 2024

Cureus

View full text Add to dashboard Cite

Diabetes mellitus (DM) is a public health concern in Brazil, with deleterious effects on quality of life and increasing mortality rates. The prevalence of diabetes in Brazil is on the rise, and it is imperative to understand its effects on mortality rates in the last two decades in order to effectively mitigate the detrimental impact of diabetes on public health. This study aims to analyze mortality trends related to diabetes in Brazil from 2000 to 2021, encompassing both type 1 and type 2 diabetes, across sex and various age cohorts. Using joinpoint regression analysis, temporal trends in Brazil were assessed, while also incorporating findings from previous studies and considering potential influencing factors, such as government initiatives and cuts in healthcare investment. The study revealed a general upward trend in mortality rates associated with DM1 and DM2 over the study period, in both males and females, with men showing a higher AAPC (average annual percent change), which translated into significantly increased mortality difference at the end of the study. Additionally, it revealed elevated mortality values for extreme age groups in the age cohorts studied, with the exception of middle-aged cohort groups in DM2, which showed an expected higher APC (annual percent change), considering the age of highest incidence of DM2 in those age groups. This comprehensive analysis provides critical insights into the escalating impact of diabetes on mortality rates in Brazil and highlights the urgent need for healthcare strategies. It is expected that the increased prevalence of diabetes in the Brazilian population adds an additional economic burden to healthcare expenditure by the Brazilian government, further worsening the health disparities among different social groups. Unless several political decisions to reduce healthcare expenditure are reversed, greater difficulties in accessing treatments will be detrimental for vulnerable social groups in Brazil. By understanding the nuanced patterns of diabetes-related mortality, healthcare providers and policymakers can allocate resources effectively and implement tailored interventions to better address diabetes in Brazil.

show abstract

Section: Type 1 Diabetes Based On Sexsupporting

confidence: 76%

Diabetes Mellitus Mortality Trends in Brazil From 2000 to 2021: An In-Depth Joinpoint Analysis

McBenedict,

Hauwanga,

Lizarazo

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

“…A major factor for vaccine uptake is the knowledge of the healthcare provider and the accessibility of vaccination for the patients [32]. In a longitudinal study that was performed in Brazil, there was an increasing number of hospitalizations by 1.83% between 2008 and 2019, and 95% of all admissions were more severe cases [33]. In the US, 30% of diabetic patients have multiple hospitalizations, which increases the nancial burden [34].…”

Section: Discussionmentioning

confidence: 99%

“…In the US, 30% of diabetic patients have multiple hospitalizations, which increases the nancial burden [34]. Vaccination in diabetic patients has been associated with a decrease in hospitalization [33][34][35]. A case-control in uenza vaccination demonstrated a 79% reduction in hospital admission [35].…”

Section: Discussionmentioning

confidence: 99%

Trends In Hepatitis B, Influenza, And Pneumococcal Vaccination In Diabetic Patients

Alzahrani

Bashrahil

Alzahrani

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Diabetes is one of the most prevalent diseases in Saudi Arabia to the extent that the country is ranked 4th in terms of incidence rate. Diabetes poses multiple health threats not only to patients but also to society and the healthcare system. Thus, numerous measures have been adapted to contain diabetes risk. One of these is the recommendation of vaccination sets for diabetic patients.Aim: This study aims to measure the coverage of hepatitis B virus (HBV), influenza, and pneumococcal vaccines in diabetic patients.Methods: Using a retrospective chart review, data were collected from 385 diabetic patients. An approved data collection sheet was used. Phone calls were utilized for subjective-based questions. The sample size was calculated via Raosoft@. Descriptive or inferential statistical analysis was performed using SPSS.Results: Type 1 and type 2 diabetic patients represented 44.2% and 55.8%, respectively. Only 15.2% of patients received influenza vaccination in the last 12 months. Approximately 14.2% of diabetic patients received the pneumococcal vaccine, while the HBV vaccination rate was 12.9%. Hospital admission within the last 12 months of influenza-vaccinated patients was 22.8%, while the unvaccinated patients recorded 77.8%. Diabetic patients reported that physicians’ recommendation rates of vaccines were 25.8% for influenza vaccine, 15.5% for pneumococcal vaccine, and 10.8% for HBV vaccine.Conclusions: Measuring vaccination rates of 12.9%, 14.2% and 15.2%, respectively, concludes that compliance with the medical recommendations of vaccinating diabetic patients is suboptimal. Healthcare institutions must collaborate with primary care physicians to integrate more efficient and adherent vaccination programs.

show abstract

“…The preponderance of male inpatient cases in the age category 40–79 is consistent with previously published results for Germany ( 4 ) and also accords with the higher prevalence of diabetes in men of this age group ( 2 , 10 ). In Brazil, where women were more frequently hospitalized, an inverse trend has been observed in the last years ( 11 ). The higher prevalence of female cases in the younger age group can be related to the higher prevalence of type 2 diabetes in young women ( 10 ), as well as to cases of gestational diabetes and of pregnancy with type 2 diabetes, which all became more frequent in the last years in Germany ( 12 , 13 ), as also seen in our results.…”

Section: Discussionmentioning

confidence: 99%

Diabetes in all hospitalized cases in Germany 2015–2019 and impact of the first COVID-19 year 2020

Auzanneau

Eckert²,

Fritsche

et al. 2023

Endocrine Connections

View full text Add to dashboard Cite

Objective: To analyze the proportion of diabetes among all hospitalized cases in Germany between 2015 and 2020. Methods: Using the nationwide Diagnosis-Related-Groups statistics, we identified among all inpatient cases aged ≥ 20 years all types of diabetes in the main or secondary diagnoses based on ICD-10 codes, as well all COVID-19 diagnoses for 2020. Results: From 2015 to 2019, the proportion of cases with diabetes among all hospitalizations increased from 18.3% (3.01 of 16.45 million) to 18.5% (3.07 of 16.64 million). Although the total number of hospitalizations decreased in 2020, the proportion of cases with diabetes increased to 18.8% (2.73 of 14.50 million). The proportion of COVID-19 diagnosis was higher in cases with diabetes than in those without in all sex and age subgroups. The relative risk (RR) for a COVID-19 diagnosis in cases with vs. without diabetes was highest in age group 40-49 years (RR in females: 1.51; in males:1.41). Conclusions: The prevalence of diabetes in the hospital is twice as high as the prevalence in the general population and has increased further with the COVID-19 pandemic, underscoring the increased morbidity in this high-risk patient group. This study provides essential information that should help to better estimate the need for diabetological expertise in inpatient care settings.

show abstract

Diabetes mellitus hospitalization and mortality rate according to a national database in Brazil: a longitudinal study

Cited by 8 publications

References 15 publications

Diabetes Mellitus Mortality Trends in Brazil From 2000 to 2021: An In-Depth Joinpoint Analysis

Diabetes Mellitus Mortality Trends in Brazil From 2000 to 2021: An In-Depth Joinpoint Analysis

Trends In Hepatitis B, Influenza, And Pneumococcal Vaccination In Diabetic Patients

Diabetes in all hospitalized cases in Germany 2015–2019 and impact of the first COVID-19 year 2020

Contact Info

Product

Resources

About